TerminatedPhase 3NCT04395339
GM1 Prophylaxis for WBRT Related Cognitive Dysfunction
Studying Gangliosidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Yat-sen University
- Principal Investigator
- Zhong-yu Yuan, M.D.Sun Yat-sen University
- Intervention
- Monosialotetrahexosyl ganglioside (GM1)(drug)
- Enrollment
- 51 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2020 – 2024
Study locations (1)
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04395339 on ClinicalTrials.govOther trials for Gangliosidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07082543A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 GangliosidosisAzafaros A.G.
- RECRUITINGPHASE1, PHASE2NCT03952637A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 GangliosidosisNational Human Genome Research Institute (NHGRI)
- RECRUITINGNCT00668187A Natural History Study of the GangliosidosesUniversity of Minnesota